Kathleen R. Cho

27.3k total citations · 7 hit papers
152 papers, 18.8k citations indexed

About

Kathleen R. Cho is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Kathleen R. Cho has authored 152 papers receiving a total of 18.8k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Molecular Biology, 42 papers in Pathology and Forensic Medicine and 42 papers in Oncology. Recurrent topics in Kathleen R. Cho's work include Ovarian cancer diagnosis and treatment (38 papers), Genetic factors in colorectal cancer (33 papers) and Cancer Genomics and Diagnostics (21 papers). Kathleen R. Cho is often cited by papers focused on Ovarian cancer diagnosis and treatment (38 papers), Genetic factors in colorectal cancer (33 papers) and Cancer Genomics and Diagnostics (21 papers). Kathleen R. Cho collaborates with scholars based in United States, Japan and Canada. Kathleen R. Cho's co-authors include Eric R. Fearon, Lora Hedrick, Bert Vogelstein, Rork Kuick, Donald R. Schwartz, Kenneth W. Kinzler, Yali Zhai, Ie−Ming Shih, Janice Nigro and J. Michael Ruppert and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Kathleen R. Cho

149 papers receiving 18.4k citations

Hit Papers

Identification of a Chromosome 18q Gene that Is Altered i... 1990 2026 2002 2014 1990 2007 2015 1991 1997 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Identification of a Chromosome 18q Gene that Is Altered in Colorectal Cancers
    1990 1.4k citations Eric R. Fearon, Kathleen R. Cho et al. profile →
  2. p53-Mediated Activation of miRNA34 Candidate Tumor-Suppressor Genes
    2007 918 citations Rork Kuick, Yali Zhai et al. profile →
  3. Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy
    2015 893 citations Dongjun Peng, Ilona Kryczek et al. Nature profile →
  4. Scrambled exons
    1991 774 citations Janice Nigro, Kathleen R. Cho et al. Cell profile →
  5. Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies.
    1997 581 citations Kathleen R. Cho, Lora H. Ellenson et al. PubMed profile →
  6. DPC4 gene in various tumor types.
    1996 570 citations Lora Hedrick, Kathleen R. Cho et al. PubMed profile →
  7. Ovarian Cancer
    2008 564 citations Kathleen R. Cho et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kathleen R. Cho United States 66 10.5k 6.3k 4.8k 3.5k 2.4k 152 18.8k
Russell R. Broaddus United States 69 5.8k 0.5× 4.9k 0.8× 4.4k 0.9× 3.5k 1.0× 3.4k 1.4× 286 15.1k
Xavier Matías‐Guiu Spain 64 6.4k 0.6× 4.2k 0.7× 3.5k 0.7× 2.4k 0.7× 3.8k 1.6× 435 16.1k
Joseph R. Testa United States 83 14.1k 1.3× 5.4k 0.9× 3.9k 0.8× 2.4k 0.7× 1.1k 0.5× 347 24.5k
David D.L. Bowtell Australia 71 11.6k 1.1× 5.4k 0.9× 3.5k 0.7× 1.3k 0.4× 3.1k 1.3× 221 18.4k
C. Blake Gilks Canada 63 4.2k 0.4× 5.0k 0.8× 3.5k 0.7× 2.3k 0.7× 4.6k 1.9× 179 14.3k
Ie‐Ming Shih United States 75 9.5k 0.9× 4.4k 0.7× 4.0k 0.8× 3.4k 1.0× 9.0k 3.8× 231 20.5k
Allen M. Gown United States 68 5.0k 0.5× 6.4k 1.0× 3.7k 0.8× 2.3k 0.7× 907 0.4× 191 16.1k
Alfredo Fusco Italy 88 17.8k 1.7× 7.9k 1.3× 7.2k 1.5× 2.8k 0.8× 618 0.3× 504 29.0k
Samuel C. Mok United States 67 7.7k 0.7× 3.5k 0.6× 3.7k 0.8× 1.2k 0.4× 4.0k 1.7× 243 14.2k
Harry Hollema Netherlands 61 3.5k 0.3× 4.0k 0.6× 2.3k 0.5× 2.3k 0.7× 1.8k 0.8× 229 11.9k

Countries citing papers authored by Kathleen R. Cho

Since Specialization
Citations

This map shows the geographic impact of Kathleen R. Cho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathleen R. Cho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathleen R. Cho more than expected).

Fields of papers citing papers by Kathleen R. Cho

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathleen R. Cho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathleen R. Cho. The network helps show where Kathleen R. Cho may publish in the future.

Co-authorship network of co-authors of Kathleen R. Cho

This figure shows the co-authorship network connecting the top 25 collaborators of Kathleen R. Cho. A scholar is included among the top collaborators of Kathleen R. Cho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathleen R. Cho. Kathleen R. Cho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Lixing, Yali Zhai, Yisheng Wang, et al.. (2021). Altering the Microbiome Inhibits Tumorigenesis in a Mouse Model of Oviductal High-Grade Serous Carcinoma. Cancer Research. 81(12). 3309–3318. 27 indexed citations
2.
Virani, Shama, Glauco Baiocchi, David D.L. Bowtell, et al.. (2021). Joint IARC/NCI International Cancer Seminar Series Report: expert consensus on future directions for ovarian carcinoma research. Carcinogenesis. 42(6). 785–793. 9 indexed citations
3.
McCool, Kevin W., Zachary T. Freeman, Yali Zhai, et al.. (2019). Murine Oviductal High-Grade Serous Carcinomas Mirror the Genomic Alterations, Gene Expression Profiles, and Immune Microenvironment of Their Human Counterparts. Cancer Research. 80(4). 877–889. 17 indexed citations
4.
Vega, Lorena Lazo de la, Kevin Hu, Nolan Bick, et al.. (2019). Multiclonality and Marked Branched Evolution of Low-Grade Endometrioid Endometrial Carcinoma. Molecular Cancer Research. 17(3). 731–740. 14 indexed citations
5.
Sakamoto, Naoya, Ying Feng, Carmine Stolfi, et al.. (2017). BRAFV600E cooperates with CDX2 inactivation to promote serrated colorectal tumorigenesis. eLife. 6. 74 indexed citations
6.
Burgos-Ojeda, Daniela, Rong Wu, Karen McLean, et al.. (2015). CD24+ Ovarian Cancer Cells Are Enriched for Cancer-Initiating Cells and Dependent on JAK2 Signaling for Growth and Metastasis. Molecular Cancer Therapeutics. 14(7). 1717–1727. 75 indexed citations
7.
McDaniel, Andrew S., Daniel H. Hovelson, Andi K. Cani, et al.. (2015). Genomic Profiling of Penile Squamous Cell Carcinoma Reveals New Opportunities for Targeted Therapy. Cancer Research. 75(24). 5219–5227. 86 indexed citations
8.
Peng, Dongjun, Ilona Kryczek, Nisha Nagarsheth, et al.. (2015). Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy. Nature. 527(7577). 249–253. 893 indexed citations breakdown →
9.
Wu, Rong, Tom C. Hu, Alnawaz Rehemtulla, Eric R. Fearon, & Kathleen R. Cho. (2011). Preclinical Testing of PI3K/AKT/mTOR Signaling Inhibitors in a Mouse Model of Ovarian Endometrioid Adenocarcinoma. Clinical Cancer Research. 17(23). 7359–7372. 60 indexed citations
10.
Coté, Michele L., Audrey E. Kam, Leon Raskin, et al.. (2011). A Pilot Study of Microsatellite Instability and Endometrial Cancer Survival in White and African American Women. International Journal of Gynecological Pathology. 31(1). 66–72. 4 indexed citations
11.
Diegel, Cassandra R., Kathleen R. Cho, Adel K. El‐Naggar, Bart O. Williams, & Charlotta Lindvall. (2010). Mammalian Target of Rapamycin–Dependent Acinar Cell Neoplasia after Inactivation of Apc and Pten in the Mouse Salivary Gland: Implications for Human Acinic Cell Carcinoma. Cancer Research. 70(22). 9143–9152. 36 indexed citations
12.
Sluis, Bart van de, Xicheng Mao, Yali Zhai, et al.. (2010). COMMD1 disrupts HIF-1α/β dimerization and inhibits human tumor cell invasion. Journal of Clinical Investigation. 120(6). 2119–2130. 103 indexed citations
13.
Zhai, Yali, Rork Kuick, Bin Nan, et al.. (2007). Gene Expression Analysis of Preinvasive and Invasive Cervical Squamous Cell Carcinomas Identifies HOXC10 as a Key Mediator of Invasion. Cancer Research. 67(21). 10163–10172. 203 indexed citations
14.
Wang, Haixing, Maureen Kachman, Donald R. Schwartz, Kathleen R. Cho, & David M. Lubman. (2004). Comprehensive proteome analysis of ovarian cancers using liquid phase separation, mass mapping and tandem mass spectrometry: A strategy for identification of candidate cancer biomarkers. PROTEOMICS. 4(8). 2476–2495. 46 indexed citations
15.
Wu, Rong, Lin Lin, David G. Beer, et al.. (2003). Amplification and Overexpression of the L-MYC Proto-Oncogene in Ovarian Carcinomas. American Journal Of Pathology. 162(5). 1603–1610. 48 indexed citations
16.
Wang, Haixing, Maureen Kachman, Donald R. Schwartz, Kathleen R. Cho, & David M. Lubman. (2002). A protein molecular weight map of ES2 clear cell ovarian carcinoma cells using a two-dimensional liquid separations/mass mapping technique. Electrophoresis. 23(18). 3168–3181. 47 indexed citations
17.
Zhai, Yali, Rong Wu, Donald R. Schwartz, et al.. (2002). Role of β-Catenin/T-Cell Factor-Regulated Genes in Ovarian Endometrioid Adenocarcinomas. American Journal Of Pathology. 160(4). 1229–1238. 88 indexed citations
18.
Schwartz, Donald R., Sharon L. R. Kardia, Kerby Shedden, et al.. (2002). Gene expression in ovarian cancer reflects both morphology and biological behavior, distinguishing clear cell from other poor-prognosis ovarian carcinomas.. PubMed. 62(16). 4722–9. 348 indexed citations
19.
20.
Nigro, Janice, Kathleen R. Cho, Eric R. Fearon, et al.. (1991). Scrambled exons. Cell. 64(3). 607–613. 774 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Russell R. Broaddus Breakdown of academic impact, for papers by Xavier Matías‐Guiu Breakdown of academic impact, for papers by Joseph R. Testa Breakdown of academic impact, for papers by David D.L. Bowtell Breakdown of academic impact, for papers by C. Blake Gilks Breakdown of academic impact, for papers by Ie‐Ming Shih Breakdown of academic impact, for papers by Allen M. Gown Breakdown of academic impact, for papers by Alfredo Fusco Breakdown of academic impact, for papers by Samuel C. Mok Breakdown of academic impact, for papers by Harry Hollema
Rankless by CCL
2026